Navigation Links
Wake Pharma US to Present Series of Wound Healing Posters at 23rd SAWC

Wake Pharma US will present a series of seven wound care education posters at 23rd Annual Symposium on Advanced Wound Care and Wound Healing Society. These posters overview the advanced science and clinical results behind the breakthrough healing gel Wound-Be-Gone, showcasing its fantastic results in a variety of clinical settings.

Elk Grove Village (PRWEB) April 15, 2010 -- Wake Pharma US announced today that seven posters detailing their revolutionary healing gel Wound-Be-Gone® will be presented at the 23rd Annual Symposium on Advanced Wound Care and Wound Healing Society (SAWC/WHS). These posters will detail impressive clinical evidence of this patented gel’s ability to help heal even the most severe and chronic wounds.

The largest event on wound healing in the country, the Annual Symposium on Advanced Wound Care and Wound Healing Society will be held at Gaylord Palms Hotel and Convention Center in Orlando, Florida, from April 17-20, 2010. Nearly a thousand posters were submitted to the symposium from renowned healing technology companies around the country, and just over three hundred were accepted by the Wound Healing Society; a series of seven posters from Wake Pharma US were accepted for display, illustrating the healing properties that their product Wound-Be-Gone® has when used on skin wounds.

These impressively well designed and technically detailed posters illustrate the profound positive impact that Wound-Be-Gone can have on even the most difficult to heal skin injuries. Says Wake Pharma US Medical Director Jeffrey Niezgoda, MD, “This extensive series of poster presentation of Wound-Be-Gone® clearly demonstrates the clinical, economic and patient benefits that can be derived from using Wound-Be-Gone®. This clinical data shows benefits in the treatment of a wide variety of wound types. As we continue to accumulate additional clinical data the evidence of accelerated healing and reduction in pain and improved patient benefits is becoming extremely compelling giving us a very favorable product profile.”

This series of seven posters covers multiple topics of great importance in the wound healing community, as follows:

Poster 1: The Wound Healing Cascade: How Oxygen Free Radicals Negatively Impact the Inflammatory Phase highlights. This poster illustrates how the advanced technology in Wound-Be-Gone® prevents bacterial growth which occurs during inflammation. It also demonstrates how the free oxygen radical binding technology in Wound-Be-Gone binds with radicals that are created during the healing process, helping to decrease swelling, speed healing, and promote healthy new tissue growth with little to no scarring.

Poster 2: Advantages of using a hydrophilic polymer gel with oxygen free radicals on Split Thickness Skin Grafts. This presentation focuses specifically on split thickness skin grafts (STSG) and how the patented formula of Wound-Be-Gone® uses its oxygen free radical binding technology to enhance healing, making treatments of such STSG faster and cost effective.

Poster 3: Advancing wound care treatment with a novel hydrophilic gel: The Practitioners and Patients Experience- Success Stories from happy patients. This educational poster provides a glimpse into the real life experience of patients who have successfully treated their challenging wounds with the revolutionary Wound-Be-Gone® gel. While this poster overviews the technology of the ointment, it focuses on the positive experiences of twenty successfully healed patients.

Poster 4: Novel Hydrophilic Gel (Wound-Be-Gone®) Enhances Healing Via Oxygen Free Radical Binding Technology. Focusing on patients who have serious leg wounds, this poster shows how healing and skin growth were encouraged through the free oxygen radical binding technology found only in Wound-Be-Gone.

Poster 5: At Home Or In A Hospital: A Simple, Yet Effective OTC Wound Gel That Makes A Wound "Be Gone.” Showcasing successful treatment in five patients within a clinical setting, this educational poster illustrates how Wound-Be-Gone® helps doctors to overcome issues of cost and effectiveness in treatments of all wounds, both acute and chronic.

Poster 6: Healing by Binding Reactive Oxygen Species (ROS). Presenting an experimental study, this poster details the results of wound healing where half of the subjects were given a simple water based gel and the others were treated with the patented formulation in Wound-Be-Gone®. This poster shows the noticeable improvement in healing experienced by study participants who were treated with Wound-Be-Gone.

Poster 7: Enhanced Cosmetic Results In African American Skin Pigmentation Using A Polymer Hydrogel With Oxygen Free Radical Binding Technology. Showing how Wound-Be-Gone does more than simply accelerate healing, this amazing poster showcases the incredible ability that Wound-Be-Gone’s free oxygen radical binding technology has when it comes to treating skin wounds in African Americans. In such dark skinned populations this novel healing gel helps wounds heal quickly, with little scarring and noticeably less de-pigmentation than is common with other wound healing regimes.

Developed by medical doctors and clinicians, and tested in extensive clinical trials, Wound-Be-Gone® has been proven an incredibly effective healing gel, as illustrated in these artistic and educational posters. Hypoallergenic and safe for all ages, Wound-Be-Gone® is available over the counter to help heal minor and serious skin injuries faster, with less scarring.

To learn more about the Annual Symposium on Advanced Wound Care and Wound Healing Society visit www. For more information about the revolutionary technology and wide array of applications for healing with Wound-Be-Gone® visit

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Centice Corporation Releases a Two Part Whitepaper on its PASS Rx Pharmacy Quality Solution
2. Synergy between behavioral and pharmacologic interventions for ADHD
3. Pharmacists Play a Vital Role in Providing Immunizations in Their Communities
4. Therapure Biopharma Inc. signs fill/finish contract with Kane Biotech Inc.
5. Amistaff Launches RN Medical/Surgical & RN Pharmacology Exams Using New Validation Process Focused on Improving Quality of Patient Care
6. PCMA: Federal Enrollees Don't Want Congress to Reduce Pharmacy Choices, Impose Price Controls in FEHBP
7. BHR Pharma Statement on Brain Injury Awareness Month - Better Awareness, Treatment, Research Needed Now
8. New Book Reviews Core Competencies for Pharmacy Leaders
9. Jazz Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
10. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results
11. Astellas Responds to OSI Pharmaceuticals Rejection
Post Your Comments:
Related Image:
Wake Pharma US to Present Series of Wound Healing Posters at 23rd SAWC
(Date:11/26/2015)... CA (PRWEB) , ... November 26, 2015 , ... ... a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly ... options. These classically-influenced trailer titles work with any font, giving users limitless opportunities ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the perfect dish and pleasing the palates of attendees is of the utmost ... dish to a seasonal get-together, give these recipes a try this holiday season. ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior government and ... Pan African Centres of Excellence, and public R&D institutions, civil societies and other ... of the 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dental professionals who would ... OH , are invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE ... Cleveland, OH. , As the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for the ... of the benefits of Botox® in the treatment of moderate facial wrinkling, few have ... pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism (the ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... 2015 --> ... devices was valued at $11,171.1 million in 2014, and ... 5.7% during 2015 - 2022. The global market is ... of diabetes. In addition, the increase in obese population ... to the growth of the market. Furthermore, technological advancements ...
Breaking Medicine Technology: